{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:06:52Z","timestamp":1768716412046,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijantimicag.2016.08.013","type":"journal-article","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T02:03:49Z","timestamp":1475373829000},"page":"564-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates"],"prefix":"10.1016","volume":"48","author":[{"given":"Po-Liang","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-En","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-0299","authenticated-orcid":false,"given":"Tsung-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Pin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0015","first-page":"172","article-title":"Addressing the challenge of extended-spectrum \u03b2-lactamases","volume":"10","author":"Zahar","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","article-title":"Fosfomycin: an old\u2013new antibiotic","volume":"18","author":"Raz","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/antibiotics2020217","article-title":"Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance","volume":"2","author":"Casta\u00f1eda-Garc\u00eda","year":"2013","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0035","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1099\/jmm.0.062653-0","article-title":"Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates","volume":"62","author":"Ho","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0040","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.1993.tb06543.x","article-title":"Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae","volume":"114","author":"O'Hara","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jmii.2010.08.012","article-title":"Antimicrobial susceptibilities of urinary extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan","volume":"44","author":"Liu","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0055","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0060","doi-asserted-by":"crossref","first-page":"e0135864","DOI":"10.1371\/journal.pone.0135864","article-title":"Characterization of fosfomycin resistant extended-spectrum \u03b2-lactamase-producing Escherichia coli isolates from human and pig in Taiwan","volume":"10","author":"Tseng","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0065","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/jac\/dkn287","article-title":"Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type \u03b2-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005\u2014the new \u2018MRSAs\u2019?","volume":"62","author":"Damjanova","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijantimicag.2011.03.020","article-title":"High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination","volume":"38","author":"Lee","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0075","first-page":"121","article-title":"Activity of fosfomycin against extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Maharaj Nakorn Chiang Mai Hospital","volume":"22","author":"Tharavichitkul","year":"2005","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0090","doi-asserted-by":"crossref","first-page":"e966","DOI":"10.1016\/j.ijid.2013.04.005","article-title":"Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey","volume":"17","author":"Demir","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0095","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0969-2126(96)00153-0","article-title":"Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin","volume":"4","author":"Skarzynski","year":"1996","journal-title":"Structure"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0100","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.08.013_bib0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2009.11.011","article-title":"Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli","volume":"35","author":"Takahata","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916302667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916302667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T20:30:01Z","timestamp":1536352201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916302667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0924857916302667"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.08.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}